|
|
|
| Application value and safety of leukocyte filtration transfusion technology in clinical blood transfusion |
| JIAO Dong-mei |
| Blood Bank, Baicheng Hospital of Jilin Province, Baicheng 137000, China |
|
|
|
|
Abstract Objective To explore and analyze the application value and safety of leukocyte filtration transfusion technology in clinical blood transfusion.Methods From June 2018 to May 2020, 80 blood transfusion patients admitted to Baicheng Hospital of Jilin Province were selected as the research objects, and they were divided into the observation group (40 cases) and the control group (40 cases) according to the computer random number table method.The observation group was treated with leukocyte filtration transfusion, while the control group was treated with conventional blood transfusion.The indexes of blood platelet, hemoglobin and white blood cell, temperature rise during blood transfusion, fibrinogen (FIB), prothrombin time (PT), activated partial thromboplastin time (APTT) and the incidence of adverse reactions were compared between the two groups.Results The levels of blood platelet, hemoglobin and white blood cell indexes of the observation group were lower than those of the control group, the differences were statistically significant (P＜0.05).The temperature rise and during blood transfusion and FIB of the observation group were lower than those of the control group, the level of PT of the observation group was shorter than that of the control group, the level of APTT of the observation group was longer than that of the control group, the differences were statistically significant (P＜0.05).The incidence of blood transfusion adverse reactions in the observation group (5.00%) was lower than that of the control group (20.00%), and the difference was statistically significant (P＜0.05).Conclusion Leukocyte filtration transfusion technology can improve the blood quality of patients with blood transfusion, prevent the risk of adverse reactions in the process of blood transfusion, and improve the therapeutic effect of blood transfusion, which is worthy of application.
|
|
Received: 13 January 2021
|
|
|
|
| [1] |
安新玲，马金平.观察滤除白细胞输血技术的临床效果[J].中国农村卫生，2020，12（18）：12.
|
| [2] |
李倩，冯妮娜.分析滤除白细胞输血技术在临床的应用效果[J].饮食保健，2019，6（47）：31-32.
|
| [3] |
陈红霞，陈栋才.不同滤除白细胞的方法对悬浮红细胞多项指标的影响分析[J].青岛医药卫生，2020，52（4）：271-274.
|
| [4] |
杨华军.滤除白细胞输血技术在临床的应用效果探讨[J].临床医药文献电子杂志，2019，6（56）：73.
|
| [5] |
朱伯平，许志晟.血常规检测中红细胞参数及白细胞计数对早期鉴别诊断贫血的价值分析[J].中国实用医药，2020，15（33）：74-76.
|
| [6] |
Hall S，Danby R，Osman H，et al.Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction：a UK dual centre experience[J].Transfus Med，2015，25（6）：418-423.
|
| [7] |
Bjursten H，Dardashti A，Bjork J，et al.Transfusion of sexmismatched and non-leukocyte-depleted red blood cells in cardiac surgery increases mortality[J].J Thoracic Cardiovasc Surg，2016，152（1）：223-232.
|
| [8] |
王民强.滤除白细胞输血技术的应用研究[J].饮食保健，2018，5（23）：252-253.
|
| [9] |
余兴南，潘水莉.滤除白细胞输血技术的临床应用分析[J].世界临床医学，2016，10（4）：66.
|
| [10] |
阿布都米吉提·于苏云，阿不都外力·阿巴拜克力.滤除白细胞输血技术的临床应用分析[J].临床医药文献电子杂志，2017，4（31）：5988-5989.
|
| [12] |
梁海云.探讨滤除白细胞输血技术的临床效果[J].心血管外科杂志（电子版），2017，6（4）：350-351.
|
| [11] |
Sobata R，Matsumoto C，Uchida S，et al.Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection（TT-HTLV-1）and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1[J].Vox Sang，2015，109（2）：122-128.
|
| [13] |
杨军，陆华，李杰，等.某院2013—2018年输血不良反应特点及影响因素分析[J].检验医学与临床，2020，17（20）：3005-3008.
|
| [14] |
许丽影.去白细胞输血预防非溶血性发热性输血反应的临床应用分析[J].中西医结合心血管病电子杂志，2020，8（33）：44，198.
|
| [15] |
van der Mast BJ，van den Dorpel MA，Drabbels JJM，et al.Transfusion-associated graft vs.host disease after donorspecific leukocyte transfusion before kidney transplantation[J].Clin Transplant，2003，17（5）：477-483.
|
| [16] |
段彩红，姬秀花.全血滤除白细胞质控抽检分析[J].宁夏医学杂志，2020，42（8）：762-763.
|
|
|
|
